Engimmune Therapeutics
Company Details
Status: Private
Employees: 11-50
Location:
Allschwil, Basel, Switzerland
Type:
sample
Technology:
sample
sample
sample
About: Engimmune is an immunotherapy company utilising cutting-edge methods for the development of T-cell receptor (TCR)-based immunotherapies including T cell therapies and biologics. By applying our unique protein engineering toolbox we have established and continue to develop proprietary high-throughput technology platforms enabling the discovery of highly potent and safe TCR-based cell therapies and biotherapeutics, thus covering the entire TCR discovery value chain.
Operating as a platform technology and product development company, our vision is to become a globally leading provider of best-in-class TCR-based therapeutics for the treatment of serious human diseases with high unmet medical need, with a particular focus on oncology.
Engimmune is based in a brand new science park in Allschwill, Basel in Switzerland
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Engimmune Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.